Lundbeck blames FDA-imposed DTC blackout for slowdown in Rexulti growth
Lundbeck has learned an unwanted lesson in the value of DTC advertising. After pushback from the FDA forced Rexulti depression ads off the air, Lundbeck reported a flattening of prescriptions that appears to be rebounding now promotion has resumed. The FDA …